Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRLM.L Regulatory News (RLM)

  • There is currently no data for RLM

Holding(s) in Company

25 Aug 2009 16:18

RNS Number : 9899X
PuriCore Plc
25 August 2009
Β 

ο»Ώ

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuerΒ of existing shares to which voting rights areΒ attached:

Puricore plc

2 Reason for the notificationΒ (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

XΒ 

An acquisition or disposal ofΒ qualifyingΒ financial instruments which may result in theΒ acquisition of shares already issuedΒ to which voting rights are attached

Β X

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

Β 

An event changing the breakdown of voting rights

Β 

Other (please specify):

Β 

3. Full name of person(s) subject to theΒ notification obligation:

Norton InvestmentΒ Fund LimitedΒ 

4. Full name of shareholder(s)Β (if differentΒ from 3.):

Β 

5. Date of the transaction and date onΒ which the threshold is crossed orΒ reached:

10thΒ August 2009Β 

6.Β Date on which issuer notified:

25thΒ August 2009Β 

7. Threshold(s) that is/are crossed orΒ reached:

Above 3%Β 

Β Β 

8. Notified details:

A: Voting rights attached to shares

Class/type of shares

if possible using the ISIN CODE

Situation previous to theΒ triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

Ordinary Shares of GBP 0.01pΒ 

Β 6,082,683

Β 6,082,683

Β 7,974,574

Β 7,974,574

Β 

Β 3.51%

Β 

Β 

B:Β QualifyingΒ Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/Β ConversionΒ Period

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

Β 870,294

27th Aug 2011Β 

Β 27th Aug 2008 - 27th Aug 2011

870,294Β 

0.38%Β 

C:Β FinancialΒ Instruments with similar economic effect to QualifyingΒ FinancialΒ Instruments

Resulting situation after the triggering transaction

Type of financial instrument

ExerciseΒ price

ExpirationΒ date

Exercise/ ConversionΒ period

Number of votingΒ rights instrumentΒ refers to

% of voting rights

Β N/A

Β N/A

Β N/A

Β N/A

Β N/A

Nominal

Delta

Β N/A

Β N/A

Total (A+B+C)

Number of voting rights

PercentageΒ of voting rights

8,844,868Β 

3.89%Β 

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

Norton Investment Fund Limited hold theΒ voting rights to the sharesΒ 

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will ceaseΒ to hold:

N/AΒ 

12. Date on which proxy holder will cease to holdΒ voting rights:

N/AΒ 

13. Additional information:

Β 

14. Contact name:

David Gannon / Brett ArmitageΒ 

15. Contact telephone number:

+44 (0) 1624 676716Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
HOLSEAFLISUSELA
Date   Source Headline
26th Mar 20197:00 amRNSCancellation of AIM Listing
25th Mar 20194:40 pmRNSSecond Price Monitoring Extn
25th Mar 20194:35 pmRNSPrice Monitoring Extension
20th Mar 201911:12 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
18th Mar 201910:31 amRNSForm 8.5 (EPT/RI) Earthport Plc
18th Mar 201910:30 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
15th Mar 20192:35 pmRNSResult of General Meeting
15th Mar 201910:09 amRNSForm 8.5 (EPT/RI) - Realm Therapeutics Plc
14th Mar 201911:01 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
13th Mar 201910:48 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
12th Mar 201911:53 amRNSForm 8.3 - Realm Therapeutics PLC
12th Mar 201910:07 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
11th Mar 201910:30 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
8th Mar 201911:30 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
7th Mar 201911:16 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
6th Mar 20199:33 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
5th Mar 20199:32 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
4th Mar 201911:41 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
1st Mar 201910:07 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
28th Feb 201911:14 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
27th Feb 20194:58 pmRNSForm 8.3 - Realm Therapeutics
27th Feb 20194:41 pmRNSSecond Price Monitoring Extn
27th Feb 20194:36 pmRNSPrice Monitoring Extension
27th Feb 201911:01 amGNWInvesco Ltd.: Form 8.3 - Realm Therapeutics PLC
26th Feb 201910:01 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
25th Feb 201910:08 amRNSForm 8.5 (EPT/RI) - Realm Therapeutics Plc
22nd Feb 201911:36 amGNWInvesco Ltd.: Form 8.3 - Realm Therapeutics PLC
22nd Feb 201910:02 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
21st Feb 20194:34 pmRNSForm 8.3 - Realm Therapeutics plc
21st Feb 20194:26 pmRNSHolding(s) in Company
21st Feb 20194:26 pmRNSHolding(s) in Company
21st Feb 201912:36 pmGNWInvesco Ltd.: Form 8.3 - Realm Therapeutics Plc
21st Feb 20199:59 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
20th Feb 201910:33 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
19th Feb 20192:05 pmRNSSecond Price Monitoring Extn
19th Feb 20192:00 pmRNSPrice Monitoring Extension
19th Feb 20199:33 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
18th Feb 20199:25 amRNSForm 8.5 (EPT/RI)Realm Therapeutics
18th Feb 20199:05 amRNSSecond Price Monitoring Extn
18th Feb 20199:00 amRNSPrice Monitoring Extension
18th Feb 20197:00 amRNSBlock listing Interim Review
18th Feb 20197:00 amRNSUpdate on Strategic Review Re-release
15th Feb 20196:20 pmRNSUpdate on Strategic Review
15th Feb 20199:22 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
13th Feb 201910:01 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
11th Feb 201910:01 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
7th Feb 20199:48 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
6th Feb 201910:48 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
5th Feb 20199:26 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
4th Feb 201911:23 amRNSForm 8.5 (EPT/RI) Realm Therapeutics

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.